Skip Nav Destination
Issues
1 August 2000
ISSN 1078-0432
EISSN 1557-3265
Editorials
Minireview
Advances in Brief
N-(4-Hydroxyphenyl)Retinamide in the Chemoprevention of Squamous Metaplasia and Dysplasia of the Bronchial Epithelium1
Jonathan M. Kurie; Jin S. Lee; Fadlo R. Khuri; Li Mao; Rodolfo C. Morice; J. Jack Lee; Garrett L. Walsh; Anita Broxson; Scott M. Lippman; Jae Y. Ro; Bonnie L. Kemp; Diane Liu; Herbert A. Fritsche; Xiaochun Xu; Reuben Lotan; Waun K. Hong
Inhaled Isotretinoin (13-cis Retinoic Acid) Is an Effective Lung Cancer Chemopreventive Agent in A/J Mice at Low doses: A Pilot Study
Alan R. Dahl; Irma M. Grossi; David P. Houchens; Laurie J. Scovell; Michael E. Placke; Anthony R. Imondi; Gary D. Stoner; Luigi M. De Luca; Dali Wang; James L. Mulshine
Clinical Trials
Comparative Pharmacokinetic Analysis of 5-Fluorouracil and Its Major Metabolite 5-Fluoro-5,6-dihydrouracil after Conventional and Reduced Test Dose in Cancer Patients1
Guido Bocci; Romano Danesi; Antonello Di Paolo; Federico Innocenti; Giacomo Allegrini; Alfredo Falcone; Alessandro Melosi; Mario Battistoni; Gemma Barsanti; Pier Franco Conte; Mario Del Tacca
Marked 24-h Rest/Activity Rhythms Are Associated with Better Quality of Life, Better Response, and Longer Survival in Patients with Metastatic Colorectal Cancer and Good Performance Status1
Marie-Christine Mormont; James Waterhouse; Pascal Bleuzen; Sylvie Giacchetti; Alain Jami; André Bogdan; Joseph Lellouch; Jean-Louis Misset; Yvan Touitou; Francis Lévi
Safety and Biodistribution of 99mTechnetium-labeled Anti-CD44v6 Monoclonal Antibody BIWA 1 in Head and Neck Cancer Patients
Joep W. G. Stroomer; Jan C. Roos; Marlies Sproll; Jasper J. Quak; Karl-Heinz Heider; Bram J. Wilhelm; Jonas A. Castelijns; Reiner Meyer; Marthin O. Kwakkelstein; Gordon B. Snow; Günther R. Adolf; Guus A. M. S. van Dongen
Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies1
Gary R. Hudes; Christine E. Szarka; Andrea Adams; Sulabha Ranganathan; Robert A. McCauley; Louis M. Weiner; Corey J. Langer; Samuel Litwin; Gwen Yeslow; Theresa Halberr; Mingxin Qian; James M. Gallo
A Cancer Gene Therapy Approach Utilizing an Anti-erbB-2 Single-Chain Antibody-encoding Adenovirus (AD21): A Phase I Trial1
Ronald D. Alvarez; Mack N. Barnes; Jesus Gomez-Navarro; Minghui Wang; Theresa V. Strong; Waleed Arafat; Ramin B. Arani; Martin R. Johnson; Bruce L. Roberts; Gene P. Siegal; David T. Curiel
Molecular Oncology, Markers, Clinical Correlates
Predictive Value of p53, mdm-2, p21, and mib-1 for Chemotherapy Response in Advanced Breast Cancer1
Johanna Sjöström; Carl Blomqvist; Päivi Heikkilä; Kristina von Boguslawski; Anne Räisänen-Sokolowski; Nils-Olof Bengtsson; Ingvil Mjaaland; Per Malmström; Björn Ostenstadt; Jonas Bergh; Erik Wist; Vahur Valvere; Eero Saksela
p53 Mutational Status Improves Estimation of Prognosis in Patients with Curatively Resected Adenocarcinoma in Barrett’s Esophagus1
Paul M. Schneider; Oliver Stoeltzing; Jack A. Roth; Arnulf H. Hoelscher; Sieglinde Wegerer; Seiichi Mizumoto; Karen Becker; Hans-J. Dittler; Ulrich Fink; J. Ruediger Siewert
Potential Role of Microvessel Density in Predicting Radiosensitivity of T1 and T2 Stage Laryngeal Squamous Cell Carcinoma Treated with Radiotherapy1
Tomoyuki Kamijo; Tomoyuki Yokose; Takahiro Hasebe; Hiroyuki Yonou; Satoshi Sasaki; Ryuichi Hayashi; Satoshi Ebihara; Hiroshi Miyahara; Hiroshi Hosoi; Atsushi Ochiai
Superoxide Dismutases in Gastric and Esophageal Cancer and the Prognostic Impact in Gastric Cancer1
A. Miranda; L. Janssen; Coen B. Bosman; Wim van Duijn; Marjan M. Oostendorp-van de Ruit; Frank J. G. M. Kubben; Gerrit Griffioen; Cornelis B. H. W. Lamers; J. Han; J. M. van Krieken; Cornelis J. H. van de Velde; Hein W. Verspaget
Expression of a Retinoid-inducible Tumor Suppressor, Tazarotene-inducible Gene-3, Is Decreased in Psoriasis and Skin Cancer1
Madeleine Duvic; Bharati Helekar; Claudia Schulz; Mimi Cho; Dan DiSepio; Carina Hager; Dominique DiMao; Parul Hazarika; Brooke Jackson; Joan Breuer-McHam; John Young; Gary Clayman; Scott M. Lippman; Roshandra A. S. Chandraratna; Nancy A. Robinson; Anne Deucher; Richard L. Eckert; Sunil Nagpal
Evidence for a Dose-Response Effect between p53 (but not p21WAF1/Cip1) Protein Concentrations, Survival, and Responsiveness in Patients with Epithelial Ovarian Cancer Treated with Platinum-based Chemotherapy1
Michael A. Levesque; Dionyssios Katsaros; Marco Massobrio; Franco Genta; Herb Yu; Giovanni Richiardi; Stefano Fracchioli; Antonio Durando; Riccardo Arisio; Eleftherios P. Diamandis
Experimental Therapeutics, Preclinical Pharmacology
Synergistic Interaction between Anti-p185HER-2 Ricin A Chain Immunotoxins and Radionuclide Conjugates for Inhibiting Growth of Ovarian and Breast Cancer Cells That Overexpress HER-21
Fengji Xu; S. Anthony Leadon; Yinhua Yu; Cinda M. Boyer; Kathy O’Briant; Kristine Ward; Amanda McWatters; Xiaoguang Zhao; Duk Soo Bae; Karen DeSombre; Michael R. Zalutsky; Robert C. Bast, Jr.
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.